Literature DB >> 9828182

Macrophages are the major source of tumor necrosis factor alpha in the porcine corpus luteum.

Y Zhao1, J A Burbach, K F Roby, P F Terranova, J D Brannian.   

Abstract

This study was designed to determine the source of tumor necrosis factor (TNF) alpha within the porcine corpus luteum (CL). 1) Sections of frozen or paraffin-embedded CL from various stages of the estrous cycle were incubated with the following primary antibodies: anti-human recombinant TNFalpha, anti-porcine macrophage-specific antigen, or anti-alpha-actin (marker of pericyte and smooth muscle cells). Dolichos biflorus lectin-peroxidase was used as an endothelial cell label. Positive immunostaining for TNFalpha was apparent in porcine CL throughout the estrous cycle. TNFalpha immunoreactivity was primarily localized in cells along septal/vascular tracts, and exhibited spatial and temporal distribution similar to that of cells labeled with anti-macrophage antibodies. Large luteal cells exhibited weak staining for TNFalpha in paraffin sections, whereas microvascular endothelial cells were consistently negative in both frozen and paraffin sections. 2) Enriched subpopulations of macrophages, endothelial cells, and large and small luteal cells were isolated by density gradient and immunomagnetic bead separation techniques. TNFalpha secretion by each subpopulation was determined by measuring bioactive TNFalpha in incubation media using a specific in vitro bioassay. Macrophage subpopulations secreted up to 100-fold greater quantities of bioactive TNFalpha (up to 400 pg/10(6) cells) than did other subpopulations. In contrast, endothelial cell and small luteal cell subpopulations released very small amounts (< 8 pg/10(6) cells) of bioactive TNFalpha. Large luteal cells secreted slightly greater amounts of TNFalpha (10-15 pg/10(6) cells). Local macrophages appear to be the primary source of TNFalpha in the porcine CL.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828182     DOI: 10.1095/biolreprod59.6.1385

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  7 in total

1.  Expressions of tumor necrosis factor-α, its receptor I, II and receptor-associated factor 2 in the porcine corpus luteum during the estrous cycle and early pregnancy.

Authors:  Chie Suzuki; Koji Yoshioka; Manabu Yamada; Toru Miyamoto; Noboru Manabe
Journal:  Vet Res Commun       Date:  2013-09-22       Impact factor: 2.459

2.  Local effects of the sphingosine 1-phosphate on prostaglandin F2alpha-induced luteolysis in the pregnant rat.

Authors:  Fatima Hernandez; Marina C Peluffo; Diana Bas; Richard L Stouffer; Marta Tesone
Journal:  Mol Reprod Dev       Date:  2009-12       Impact factor: 2.609

3.  Expression and regulation of tumor necrosis factor (TNF) and TNF-receptor family members in the macaque corpus luteum during the menstrual cycle.

Authors:  Marina C Peluffo; Kelly A Young; Jon D Hennebold; Richard L Stouffer
Journal:  Mol Reprod Dev       Date:  2009-04       Impact factor: 2.609

4.  Changes in Porcine Corpus Luteum Proteome Associated with Development, Maintenance, Regression, and Rescue during Estrous Cycle and Early Pregnancy.

Authors:  Pawel Likszo; Dariusz Jan Skarzynski; Beenu Moza Jalali
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

5.  Signaling mechanisms in tumor necrosis factor alpha-induced death of microvascular endothelial cells of the corpus luteum.

Authors:  James K Pru; Maureen P Lynch; John S Davis; Bo R Rueda
Journal:  Reprod Biol Endocrinol       Date:  2003-02-11       Impact factor: 5.211

Review 6.  Multiple roles of TNF super family members in corpus luteum function.

Authors:  Kiyoshi Okuda; Ryosuke Sakumoto
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

7.  The expression of tumor necrosis factor-alpha, its receptors and steroidogenic acute regulatory protein during corpus luteum regression.

Authors:  Michael Abdo; Susan Hisheh; Frank Arfuso; Arun Dharmarajan
Journal:  Reprod Biol Endocrinol       Date:  2008-11-07       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.